IVF Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
2.2M
+8.0%
2.0M
+27.3%
1.6M
-9.9%
1.8M
-5.7%
1.9M
Cost of Revenue
1.4M
+9.7%
1.3M
+23.0%
1.0M
-7.2%
1.1M
+3.1%
1.1M
Gross Profit
762.7K
+4.8%
727.8K
+35.6%
536.9K
-14.7%
629.3K
-18.3%
770.1K
Operating Expenses
2.1M
-11.5%
2.3M
+19.0%
1.9M
-13.9%
2.3M
-39.8%
3.8M
R&D
0
0
0
0
0
SG&A
1.9M
-12.4%
2.2M
+20.0%
1.8M
-14.8%
2.1M
-3.0%
2.2M
Operating Income
-1289650
+18.9%
-1590971
-12.7%
-1412256
+13.6%
-1635484
+45.3%
-2990088
EBITDA
-1144077
+21.0%
-1448273
-13.5%
-1275831
+14.9%
-1498743
-5.3%
-1422999
Net Income
888.7K
+116.0%
-5539351
-375.6%
2.0M
+176.0%
-2644625
+26.9%
-3618969
EPS (Basic)
$0.42
+112.4%
$-3.38
$-0.77
+99.8%
$-364.23
EPS (Diluted)
$0.35
+110.4%
$-3.38
$-0.77
+99.8%
$-364.23
Shares (Diluted)
2.6M
+58.3%
1.6M
3.4M
+34598.3%
9.9K
INVO Fertility (IVF) — Financials